About
STIMIT AG is a Swiss Medtech company founded in 2018, with headquarters in Biel and an additional site in Zurich. The company focuses on developing non-invasive technology to activate and preserve the diaphragmatic breathing muscles of patients who are mechanically ventilated. Their core product, the STIMIT Activator 1, is a temporary phrenic nerve stimulation device that helps maintain diaphragm thickness and function during invasive mechanical ventilation. The STIMIT Activator 1 uses targeted electromagnetic fields for diaphragm neurostimulation and has received market approval in Canada as a Class II medical device. It is currently undergoing an FDA Investigational Device Exemption clinical trial in collaboration with clinical centers in North America. STIMIT AG was acquired by Drägerwerk AG & Co KGaA in April 2021, which aims to enhance the development and clinical validation of this innovative therapy. The company collaborates with leading clinics in Switzerland, Germany, and the USA, supported by Swiss institutions for engineering and design expertise.
Technologies
Keywords
Company Information
-
Employees 7
-
Founded 2018
-
Annual Revenue $5000000
-
Total Funding $102424
Location
46 Aarbergstrasse, Biel/Bienne, Canton of Bern, Switzerland, 2503